“The Congressional Budget Office found on Friday that a revised drug pricing plan eyed by Senate Democrats as part of their party-line social spending plans would bring in $287 billion in revenue over 10 years. That’s a big chunk of what they’re hoping to accomplish through their push,” Politico reports.
“That comes on the heels of a plan from Democrats to boost a 3.8 percent surcharge on investment income as part of the package, which leaders think could raise $200 billion in revenue.”
Overall, Democrats are “working toward legislation that provides $1 trillion in new revenues, half of which would go toward deficit reduction and half of which would go toward energy and health spending.”
